About the journal
Clinical Neuropharmacology is a journal published by Lippincott Williams & Wilkins in United States. It is listed in MEDLINE according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Lippincott Williams & Wilkins
- ISSN
- 0362-5664 · 1537-162X
- Country
- United States
- Access
- Not open access / not declared
- Official website
- http://journals.lww.com/clinicalneuropharm/Pages/default.aspx
Index listings
- MEDLINE · 1982-01-01
- Indexing
- MEDLINE
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
5024
Last recorded publication year
2026
h-index
106
i10-index
1844
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 64%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 7607910
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Parkinson's Disease Mechanisms and Treatments
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neurological disorders and treatments
- Epilepsy research and treatment
- Epilepsy research and treatment
- Schizophrenia research and treatment
- Schizophrenia research and treatment
Show all subjects (50)
- Treatment of Major Depression
- Treatment of Major Depression
- Neuroscience and Neuropharmacology Research
- Neuroscience and Neuropharmacology Research
- Pharmacological Effects and Toxicity Studies
- Pharmacological Effects and Toxicity Studies
- Electroconvulsive Therapy Studies
- Electroconvulsive Therapy Studies
- Neurotransmitter Receptor Influence on Behavior
- Neurotransmitter Receptor Influence on Behavior
- Botulinum Toxin and Related Neurological Disorders
- Botulinum Toxin and Related Neurological Disorders
- Bipolar Disorder and Treatment
- Bipolar Disorder and Treatment
- Attention Deficit Hyperactivity Disorder
- Attention Deficit Hyperactivity Disorder
- Sleep and Wakefulness Research
- Sleep and Wakefulness Research
- Parkinson's Disease and Spinal Disorders
- Parkinson's Disease and Spinal Disorders
- Obsessive-Compulsive Spectrum Disorders
- Obsessive-Compulsive Spectrum Disorders
- Tryptophan and brain disorders
- Tryptophan and brain disorders
- Diet and metabolism studies
- Diet and metabolism studies
- Pharmacological Receptor Mechanisms and Effects
- Pharmacological Receptor Mechanisms and Effects
- Neurological and metabolic disorders
- Neurological and metabolic disorders
- Glycogen Storage Diseases and Myoclonus
- Glycogen Storage Diseases and Myoclonus
- Genetic Neurodegenerative Diseases
- Genetic Neurodegenerative Diseases
- Sleep and related disorders
- Receptor Mechanisms and Signaling
- Sleep and related disorders
- Receptor Mechanisms and Signaling
- Alcoholism and Thiamine Deficiency
- Alcoholism and Thiamine Deficiency
- Stress Responses and Cortisol
- Stress Responses and Cortisol
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ